ToolGen
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Byucksan Digital Valley 6-cha 219 Gasan ...Phone Number
+82 28738168Website
www.toolgen.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ToolGen
ToolGen, Inc. (KONEX 199800) is a biotechnology company focused on the development and application of genome editing technologies. It creates and holds intellectual property rights for essential tools and technologies for editing the genetic information in microbial, plant, animal, and human cells. ToolGen's mission is to translate the potential of its innovative platform technology into transformative products for biomedicine and agriculture.Explore more
ToolGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ToolGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ToolGen had a recent Job posting/layoffs
Check if ToolGen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ToolGen launches new products
Check out if ToolGen is spiking on competitors!
Earning: See what the market has to say on ToolGen recently announced quarterly report
ToolGen, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ToolGen has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ToolGen
Recommended Actions
Find VP level buyers at ToolGen
Find more new buyers
Company Profile Activity
Activity Insights
ToolGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ToolGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ToolGen.
ToolGen Tech Stack
A closer look at the technologies used by ToolGen
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Partnership
Integration, Partnership, Digital Technology, Medical Research, Clinical Operations, Healthcare Operations, Healthcare Technology
Project
Intellectual Property, Healthcare Technology
Project
Intellectual Property, Lawsuits, Legal Affairs, Governmental Affairs & Regulation, Pharmaceuticals, Regulations
ToolGen News & Media
ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a Hong Kong-headquartered cliGenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea and HONG KONG, Nov. 24, 2025 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a Hong Kong-headquartered clinical-stage biotechnology company specializing in novel deliveries, including lipid nanoparticle (LNP)-based delivery systems, announced today thatToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY®
- U.S. patent granted for CRISPR-Cas9 RNP platform technology in the world's largest biotech market - Next-generation platform that enhances editing efficiency and accuracy strengthens ToolGen's global patent portfolio - Following actions in Europe, ToolGen initiates U.S. litigation...ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands
Lawsuit filed against Lonza, the Dutch manufacturer of the world's first CRISPR-based genome editing therapy, CASGEVY Second European action following UK litigation, enforcing ToolGen's rights to fundamental CRISPR-Cas9 RNP technology SEOUL, South Korea, Sept. 8, 2025 /PRNewswire/ --...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ToolGen
Sign Up For FreeTo access detailed company insights
ToolGen, Inc. (KONEX 199800) is a biotechnology company focused on the development and application of genome editing technologies. It creates and holds intellectual property rights for essential tools and technologies for editing the genetic information in microbial, plant, animal, and human cells. ToolGen's mission is to translate the potential of... Read More
